• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用等电聚焦和等位基因特异性寡核苷酸杂交技术对抗凝血酶III进行基因研究。

Genetic studies of antithrombin III with IEF and ASO hybridization.

作者信息

Dürr C, Hinney A, Luckenbach C, Kömpf J, Ritter H

机构信息

Institut für Anthropologie und Humangenetik der Universität, Tübingen, Federal Republic of Germany.

出版信息

Hum Genet. 1992 Dec;90(4):457-9. doi: 10.1007/BF00220477.

DOI:10.1007/BF00220477
PMID:1483705
Abstract

Antithrombin III (AT III) was analyzed by two different methods. Isoelectric focusing was used to screen 3 different populations (southwest Germans, Portuguese, Xavante Indians). The same variant was detected both in the German and the Portuguese populations with frequencies of 0.007 and 0.00024, respectively. Further characterization of this variant was performed by allele specific oligonucleotides. By this means, it was possible to identify the variant as AT III Dublin, originally found in 4 Irish families.

摘要

采用两种不同方法对抗凝血酶III(AT III)进行分析。利用等电聚焦技术对三个不同人群(德国西南部人群、葡萄牙人群、沙万特印第安人)进行筛查。在德国人和葡萄牙人群中均检测到同一变异体,其频率分别为0.007和0.00024。通过等位基因特异性寡核苷酸对该变异体进行进一步鉴定。通过这种方法,有可能将该变异体鉴定为最初在4个爱尔兰家族中发现的AT III都柏林变异体。

相似文献

1
Genetic studies of antithrombin III with IEF and ASO hybridization.采用等电聚焦和等位基因特异性寡核苷酸杂交技术对抗凝血酶III进行基因研究。
Hum Genet. 1992 Dec;90(4):457-9. doi: 10.1007/BF00220477.
2
Antithrombin III Kumamoto: identification of a point mutation and genotype analysis of the family.抗凝血酶III熊本型:一个点突变的鉴定及家系的基因型分析
Thromb Haemost. 1990 Apr 12;63(2):231-4.
3
Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT----TGT) and antithrombin III Glasgow (393 CGT----CAT).合成寡核苷酸在抗凝血酶III诺斯威克公园型(393位CGT----TGT)和抗凝血酶III格拉斯哥型(393位CGT----CAT)特性鉴定中的应用。
Blood. 1988 Nov;72(5):1817-21.
4
Antithrombin III Padua 2: a single base substitution in exon 2 detected with PCR and direct genomic sequencing.抗凝血酶III帕多瓦2型:通过聚合酶链反应和直接基因组测序在外显子2中检测到的单碱基替换。
Nucleic Acids Res. 1990 Apr 11;18(7):1926. doi: 10.1093/nar/18.7.1926.
5
CpG dinucleotides are "hotspots" for mutation in the antithrombin III gene. Twelve variants identified using the polymerase chain reaction.CpG二核苷酸是抗凝血酶III基因中的突变“热点”。使用聚合酶链反应鉴定出12种变体。
Mol Biol Med. 1989 Jun;6(3):239-43.
6
Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, "antithrombin III Toyama".
Thromb Res. 1987 Jul 15;47(2):147-53. doi: 10.1016/0049-3848(87)90371-9.
7
Antithrombin III-Amiens: a new family with an Arg47----Cys inherited variant of antithrombin III with impaired heparin cofactor activity.
Am J Hematol. 1991 Jan;36(1):25-9. doi: 10.1002/ajh.2830360106.
8
Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.抗凝血酶都柏林(-3缬氨酸----谷氨酸):一种具有异常信号肽酶切割位点的N端变体。
FEBS Lett. 1990 Oct 29;273(1-2):87-90. doi: 10.1016/0014-5793(90)81057-u.
9
Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.使用聚合酶链反应对抗凝血酶III(ATIII)变体进行分子特征分析。鉴定出ATIII沙勒维尔型为Ala 384 Pro突变。
J Clin Invest. 1989 Oct;84(4):1236-42. doi: 10.1172/JCI114290.
10
Trinucleotide repeat polymorphism in the human antithrombin III (AT3) gene.
Hum Mol Genet. 1993 May;2(5):618. doi: 10.1093/hmg/2.5.618-a.

引用本文的文献

1
Antithrombin, Protein C, and Protein S: Genome and Transcriptome-Wide Association Studies Identify 7 Novel Loci Regulating Plasma Levels.抗凝血酶、蛋白 C 和蛋白 S:全基因组和转录组关联研究鉴定出 7 个调节血浆水平的新基因座。
Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):e254-e269. doi: 10.1161/ATVBAHA.122.318213. Epub 2023 Apr 27.

本文引用的文献

1
Identification and characterization of a new antithrombin III familial variant (AT Dublin) with possible increased frequency in children with cancer.一种新的抗凝血酶III家族变异体(抗凝血酶都柏林)的鉴定与特征分析,该变异体在癌症患儿中的出现频率可能增加。
Br J Haematol. 1987 Apr;65(4):457-62. doi: 10.1111/j.1365-2141.1987.tb04150.x.
2
A simple salting out procedure for extracting DNA from human nucleated cells.一种从人有核细胞中提取DNA的简单盐析方法。
Nucleic Acids Res. 1988 Feb 11;16(3):1215. doi: 10.1093/nar/16.3.1215.
3
Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.
抗凝血酶III犹他型:抑制剂反应位点附近高度保守区域中的脯氨酸407突变为亮氨酸
Biochemistry. 1988 Aug 9;27(16):6171-8. doi: 10.1021/bi00416a052.
4
Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.使用聚合酶链反应对抗凝血酶III(ATIII)变体进行分子特征分析。鉴定出ATIII沙勒维尔型为Ala 384 Pro突变。
J Clin Invest. 1989 Oct;84(4):1236-42. doi: 10.1172/JCI114290.
5
Antithrombin: structure, genomic organization, function and inherited deficiency.抗凝血酶:结构、基因组组织、功能及遗传性缺陷
Baillieres Clin Haematol. 1989 Oct;2(4):961-98. doi: 10.1016/s0950-3536(89)80054-x.
6
Molecular genetics of inherited antithrombin III deficiencies.
Am J Med. 1989 Sep 11;87(3B):15S-18S. doi: 10.1016/0002-9343(89)80525-x.
7
Antithrombin III.抗凝血酶III
Int J Biochem. 1990;22(2):121-8. doi: 10.1016/0020-711x(90)90172-y.
8
Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.抗凝血酶都柏林(-3缬氨酸----谷氨酸):一种具有异常信号肽酶切割位点的N端变体。
FEBS Lett. 1990 Oct 29;273(1-2):87-90. doi: 10.1016/0014-5793(90)81057-u.